Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib with Cisplatin/Gemcitabine in Squamous NSCLC
NCT00735904Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of axitinib in squamous cell carcinoma of the lung (SCCL), sponsored by Pfizer. Started Dec 2008; status: completed.
02
Drugs
axitinib
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT00735904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735904.